Literature DB >> 29221513

Life Expectancy, Causes of Death, Risk Factors in China and the U.S.

Zhengjun Li1, Yaoyao Bian2, Li Zeng3, Wenlin Li4, Lili Yang5.   

Abstract

Mesh：

Year:  2017        PMID： 29221513     DOI： 10.1016/j.aogh.2017.10.003

Source DB:  PubMed          Journal:  Ann Glob Health        ISSN： 2214-9996            Impact factor:   2.462


× No keyword cloud information.
  1 in total

1.  Fruquintinib with gefitinib as first-line therapy in patients carrying EGFR mutations with advanced non-small cell lung cancer: a single-arm, phase II study.

Authors:  Shun Lu; Jian-Ying Zhou; Xiao-Min Niu; Jian-Ya Zhou; Hong Jian; Hong-Yan Yin; Sha Guan; Lin-Fang Wang; Ke Li; James He; Wei-Guo Su
Journal:  Transl Lung Cancer Res       Date:  2021-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.